Obesity is one of the leading risk factors for developing renal cell carcinoma, an immunogenic tumor that is treated clinically with immunostimulatory therapies. Currently, however, the mechanisms lin
aEstimates adjusted for sex, country of birth, quintile of socioeconomic status, body size at baseline, cumulative smoking status, and the following covariates measured at baseline and wave 2: physica
